Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
In 2016, the World Health Organization updated its classification of tumors, adding genetic profiles to the conventional histopathologic typing. The authors present herein the first case of a 44-year-old female with isocitrate dehydrogenase-mutant World Health Organization grade II diffuse spinal astrocytoma diagnosed on the basis of both histopathologic and genetic findings. The present case underscores the significant role of a molecular genetic analysis in the differential diagnosis of intramedullary spinal gliomas.